Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts

被引:18
作者
Schui, DK [1 ]
Singh, L [1 ]
Schneider, B [1 ]
Knau, A [1 ]
Hoelzer, D [1 ]
Weidmann, E [1 ]
机构
[1] Goethe Univ Frankfurt, Dept Med 3, D-60590 Frankfurt, Germany
关键词
dendritic cells; acute myeloid leukemia; immunotherapy; cytotoxic T cells; blast cell lysates; tetanus toxoid;
D O I
10.1016/S0145-2126(01)00141-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dendritic cells (DCs) were established from 25 patients in complete remission of acute myeloid leukemia (AML). In patients during hematopoietic regeneration following chemotherapy the yield of DC was comparable to that of healthy donors. In patients. more than 2 months after chemotherapy, significantly less DC were generated. Comparison of the antigen-presenting capacity using tetanus toxoid of six AML patients and six healthy volunteers did not show significant differences. In six AML patients, lymphocytes stimulated with blast cell lysate pulsed DC were analyzed for cytotoxic activity against autologous blast cells. 8.4-35.6% of autologous blast cells were lysed by DC stimulated lymphocytes. In three of the six patients maximum lysis of target cells was achieved by unpulsed DC. Thus, it seems that in some patients blast cell lysates mediate inhibitory effects, which may explain to some extend immune escape mechanisms in AML. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 32 条
  • [1] Bergmann L, 1995, EXP HEMATOL, V23, P1574
  • [2] BERNHARD H, 1995, CANCER RES, V55, P1099
  • [3] Development of dendritic cells and their use in tumor therapy
    Björck, P
    [J]. CLINICAL IMMUNOLOGY, 1999, 92 (02) : 119 - 127
  • [4] Buchele S, 1997, ADV EXP MED BIOL, V417, P233
  • [5] Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells
    Cardoso, AA
    Seamon, MJ
    Afonso, HM
    Ghia, P
    Boussiotis, VA
    Freeman, GJ
    Gribben, JG
    Sallan, SE
    Nadler, LM
    [J]. BLOOD, 1997, 90 (02) : 549 - 561
  • [6] Charbonnier A, 1999, EUR J IMMUNOL, V29, P2567, DOI 10.1002/(SICI)1521-4141(199908)29:08<2567::AID-IMMU2567>3.0.CO
  • [7] 2-S
  • [8] Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses
    Choudhury, A
    Liang, JC
    Thomas, EK
    Flores-Romo, L
    Xie, QS
    Agusala, K
    Sutaria, S
    Sinha, I
    Champlin, RE
    Claxton, DF
    [J]. BLOOD, 1999, 93 (03) : 780 - 786
  • [9] Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia
    Choudhury, A
    Gajewski, JL
    Liang, JC
    Popat, U
    Claxton, DF
    Kliche, KO
    Andreeff, M
    Champlin, RE
    [J]. BLOOD, 1997, 89 (04) : 1133 - 1142
  • [10] Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes
    Falkenburg, JHF
    Wafelman, AR
    Joosten, P
    Smit, WM
    van Bergen, CAM
    Bongaerts, R
    Lurvink, E
    van der Hoorn, M
    Kluck, P
    Landegent, JE
    Kluin-Nelemans, HC
    Fibbe, WE
    Willemze, R
    [J]. BLOOD, 1999, 94 (04) : 1201 - 1208